---
schema_version: "secwatch.filing_event.v1"
accession: "0001770787-24-000058"
form_type: "8-K"
ticker: "TXG"
cik: "0001770787"
company_name: "10x Genomics, Inc."
filed_at: "2024-08-08T23:59:59+00:00"
generated_at: "2026-05-31T11:06:43.859027+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# 10x Genomics reports Q2 revenue $153.1M (+4% YoY), guides FY24 down to $640-660M; CFO resigns, Taich appointed

## Summary
- Q2 revenue $153.1M, +4% YoY; net loss $37.9M vs $62.4M loss in prior year.
- Operating expenses down 10% to $146.0M; gross margin flat at 68%.
- Full year 2024 revenue guidance lowered to $640-660M from $670-690M (3-7% growth).
- CFO Justin McAnear resigns effective Aug 30; Adam Taich appointed CFO effective Aug 12.
- Mennah Moustafa named Chief Commercial Officer effective Aug 1.

## SEC filing metadata
- accession: 0001770787-24-000058
- form_type: 8-K
- ticker: TXG
- cik: 0001770787
- company_name: 10x Genomics, Inc.
- filed_at: 2024-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1770787/000177078724000058/0001770787-24-000058-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1770787/000177078724000058/txg-20240806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001770787-24-000058
- JSON: https://secwatch.observer/filing/0001770787-24-000058.json
- Plain text: https://secwatch.observer/filing/0001770787-24-000058.txt

## Key facts
- Executive change
  Justin J. McAnear resigned as Chief Financial Officer at 10x Genomics, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: Justin J. McAnear, who on August 6, 2024 notified the Company of his intention to resign and who will continue to provide transition services as an employee of the Company through August 30, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1770787/000177078724000058/0001770787-24-000058-index.htm
- Executive change
  Adam S. Taich was appointed as Chief Financial Officer at 10x Genomics, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On August 8, 2024, the Company announced that Adam S. Taich will be joining the Company as its Chief Financial Officer, effective August 12, 2024, replacing Justin J. McAnear
  evidence_url: https://www.sec.gov/Archives/edgar/data/1770787/000177078724000058/0001770787-24-000058-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.